Global Combination Products Market, 2021-2027

February 2022 | 85 pages | ID: GE973ADD07F8EN
Gen Consulting Company

Abstracts

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product. The global combination products market is anticipated to reach valuation of ~USD 147,447 million by 2027, representing a CAGR of 7.1% from 2021 to 2027 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global combination products market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The combination products market is segmented on the basis of product, application, end user, and region. The combination products market is segmented as below:

By product:

• drug/device and biologic/device combination products
• drug/biologic combination products
• drug/device/biologic combination products

By application:

• cardiovascular diseases (CVDs)
• metabolic disorders
• oncology
• orthopedic disorders
• respiratory diseases
• wound care
• others

By end user:

• hospitals
• ambulatory surgical centers (ASCs)
• others

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report has also analysed the competitive landscape of the global combination products market with some of the key players being Abbott Laboratories, AbbVie Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cipla Limited, CosMED Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Novartis International AG, Novo Nordisk A/S, Sanofi S.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global combination products market.
• To classify and forecast the global combination products market based on product, application, end user, and region.
• To identify drivers and challenges for the global combination products market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global combination products market.
• To identify and analyze the profile of leading players operating in the global combination products market.

Why Choose This Report

• Gain a reliable outlook of the global combination products market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR COMBINATION PRODUCTS BY PRODUCT

5.1 Drug/device and biologic/device combination products
  5.1.1 Market size and forecast
5.2 Drug/biologic combination products
  5.2.1 Market size and forecast
5.3 Drug/device/biologic combination products
  5.3.1 Market size and forecast

PART 6. GLOBAL MARKET FOR COMBINATION PRODUCTS BY APPLICATION

6.1 Cardiovascular diseases (CVDs)
  6.1.1 Market size and forecast
6.2 Metabolic disorders
  6.2.1 Market size and forecast
6.3 Oncology
  6.3.1 Market size and forecast
6.4 Orthopedic disorders
  6.4.1 Market size and forecast
6.5 Respiratory diseases
  6.5.1 Market size and forecast
6.6 Wound care
  6.6.1 Market size and forecast
6.7 Others
  6.7.1 Market size and forecast

PART 7. GLOBAL MARKET FOR COMBINATION PRODUCTS BY END USER

7.1 Hospitals
  7.1.1 Market size and forecast
7.2 Ambulatory surgical centers (ASCs)
  7.2.1 Market size and forecast
7.3 Others
  7.3.1 Market size and forecast

PART 8. GLOBAL MARKET FOR COMBINATION PRODUCTS BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Abbott Laboratories
9.2 AbbVie Inc.
9.3 B. Braun Melsungen AG
9.4 Becton, Dickinson and Company
9.5 Boston Scientific Corporation
9.6 Cipla Limited
9.7 CosMED Pharmaceutical Co., Ltd.
9.8 GlaxoSmithKline plc
9.9 Johnson & Johnson
9.10 Medtronic plc
9.11 Novartis International AG
9.12 Novo Nordisk A/S
9.13 Sanofi S.A.
9.14 Smith & Nephew plc
9.15 Stryker Corporation
9.16 Terumo Corporation
9.17 W. L. Gore & Associates, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY